Finance stocks are abundant in the IBD 50, although several are extended from buy points or from main moving averages. This group is notable for its strong fundamentals and price outperformance, which are two of the four pillars of The IBD Methodology.
Ryan Specialty (RYAN) is lingering within a buy range from a cup base’s 69.03 buy point. The stock has pulled back from its all-time high of 73.10, yet is finding a footing close to its 10-day moving average. While that augurs well for its Oct. 1 breakout, earnings risk looms, with fiscal third-quarter results due Oct. 30.
↑
X
How To Buy Stocks: Bases And Buy Points
According to MarketSurge pattern recognition, the most recent base was early stage.
Shares gapped up on Aug. 2, after second-quarter sales grew 19% to $695.4 million while earnings of 58 cents per share rose 29%.
Analysts polled by FactSet expect third quarter sales of $602 million with earnings of 41 cents per share.
Ryan Specialty provides specialty insurance products and services such as underwriting, while also helping with the administration and management risk for insurance providers.
Both the 97 Composite Rating and EPS Rating of 98 show the stock has outperformed the majority of stocks in Investor’s Business Daily’s vast database. Its EPS Rating is also the best of 16 companies in its group. The Relative Strength Rating of 92 is also outstanding. However, the relative strength line has started to lag a bit.
Ryan stock also ranks first in the insurance brokers industry group, which ranks No. 81 among IBD’s 197 industry groups.
More Insurance, Finance Stocks In the IBD 50
Also in the insurance brokers group, Baldwin Insurance (BWIN) has shown steady sales growth over the last eight quarters. EPS growth ranged from 17% to 61% for the most recent four quarters.
Shares have risen along a sharply upward sloping 50-day moving average and are extended. The relative strength line has kept pace, showing strong outperformance vs. the S&P 500.
Interactive Brokers (IBKR) holds an ideal Composite Rating of 99, while the EPS Rating is 96. But shares are extended from their most recent buy point of 129.19.
Clearwater Analytics (CWAN) is in a profit zone from a buy point of 21.89 and is just past a 3% buying range from a three-weeks-tight entry of 26.03. Clearwater provides a platform for investment management and accounting.
Shift4 Among Top Stocks
In payments processing, finance stock Shift4 (FOUR) also has delivered steady sales growth. Earnings growth slowed to 6% in Q1, an outlier in a trend of 30% to 86% gains the last four quarters. The stock is under strong accumulation in recent weeks, with an Accumulation/Distribution Rating of A.
Strong fiscal second-quarter results on Aug. 8 sparked a rally, and shares broke out of a cup-with-handle base Sept. 13 at 84.26. The stock is extended now.
Also in the payments group, Affirm (AFRM) is trying to break out of a handle entry at 47.98. Shares gapped up on Aug. 29 after losses narrowed in its June-ended quarter. But the stock faces resistance around 50.
Sezzle (SEZL), which went public in August 2023, has soared to an all-time high and holds an ideal Composite Rating of 99. Sezzle also offers a payments platform. Shares have gained a staggering 967% year to date. That makes it one of 2024’s big winners, beating even a leader like Nvidia (NVDA), which has gained 180% this year.
Here are gains for all seven stocks based on Thursday’s closing price.
| Symbol | Year To Date Gain |
|---|---|
| RYAN | 64% |
| FOUR | 27% |
| CWAN | 35% |
| BWIN | 130% |
| SEZL | 967% |
| AFRM | -0.02% |
| IBKR | 80% |
Please follow VRamakrishnan on X/Twitter for more news on the stock market today.
YOU MAY ALSO LIKE:
IBD Live: Learn And Analyze Growth Stocks With The Pros
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
MarketSurge: Research, Charts, Data And Coaching All In One Place
